Optinose Announces Late Breaking Abstract Podium Presentation at IDWeek 2022
October 21, 2022 07:00 ET | Optinose, Inc.
Presentation highlights a greater than 60% reduction in acute exacerbations and need for antibiotics for chronic sinusitis patients who used XHANCE in landmark ReOpen phase 3 clinical trial program ...
GeoVax Announces Upcoming Presentations at Scientific Conferences
May 04, 2022 09:00 ET | GeoVax, Inc.
ATLANTA, GA, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire –GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases...
vTv Graps Logo.png
vTv Therapeutics to Present Additional Positive Clinical Study Results from Phase 2 Simplici-T1 Study of TTP399 as Adjunctive Therapy for Patients with Type 1 Diabetes at EASD Virtual Meeting
September 16, 2020 07:30 ET | vTv Therapeutics Inc.
HIGH POINT, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced it will deliver two oral presentations emphasizing the potential of TTP399 as an oral...
vTv Graps Logo.png
vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes
September 18, 2019 07:30 ET | vTv Therapeutics Inc.
HIGH POINT, N.C., Sept. 18, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), today presented additional positive data from its phase 2 Simplici-T1 study in patients with type 1...
vTv Graps Logo.png
vTv Therapeutics to Present Posters at Two Scientific Conferences in September
September 11, 2019 07:30 ET | vTv Therapeutics Inc.
 Presenting New Clinical Data from Phase 2 Study in Type 1 Diabetes with Liver Selective GKA Program Pre-Clinical Data in NASH with the NRF2/Bach1 Program  HIGH POINT, N.C., Sept. 11, 2019 (GLOBE...
Ondine President, Dr
Ondine President, Dr. Nicolas Loebel, Plenary Speaker at the 17th World Congress of the International Photodynamic Association
July 24, 2019 11:13 ET | Ondine Biomedical Inc.
Vancouver, Canada, July 24, 2019 (GLOBE NEWSWIRE) -- Recognized as a global expert in the emerging field of antimicrobial photodynamic therapy, Dr. Nicolas Loebel, President and Chief Technology...
Optinose to Highlight Data at Two Upcoming Scientific Meetings
October 03, 2018 07:00 ET | OptiNose, Inc.
YARDLEY, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Immune Design Logo
Immune Design Announces Multiple Presentations at CTOS and SITC Highlighting the Breadth of Existing & Future Product Candidates
November 07, 2017 08:00 ET | Immune Design Corp.
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced seven...
Welcome Reception WAHC
International Aquatic Conference Aims To Bring Leaders Together
May 17, 2016 14:31 ET | National Swimming Pool Foundation
COLORADO SPRINGS, Colo., May 17, 2016 (GLOBE NEWSWIRE) -- The World Aquatic Health™ Conference (WAHC), the leading educational and scientific conference in the aquatics industry, will be in...
Immune Design Logo
Immune Design’s GLAAS™ Platform Shown to Modulate the Allergic Immune Response
March 04, 2016 08:00 ET | Immune Design Corp.
Establishes Potential for the Treatment of Pollen and Peanut Allergies Data Presented at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting SEATTLE and SOUTH...